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The acquired immune deficiency syndrome (AIDS) 
appeared in the United States in late 1978 and has 
spread at an epidemic rate through the four major 
coastal cities of this country. The disease appears to 
show the same epidemiologic distribution as hepatitis B 
virus infection, and for this reason, most investigators 
feel that this new disease is caused by a blood-borne 
sexually transmitted virus. 
A number of viral agents have been suggested as the 
cause of AIDS, but to date, no virus has been consistently 
isolated. The most likely candidate is a retrovirus that 
has recently been introduced into the human population 
and has found its way into two extremely high-risk 
groups, namely, promiscuous male homosexuals and in­
travenous drug abusers. 
The relationship between Kaposi's sarcoma and cyto­
megalovirus is still unclear, but evidence is mounting 
that cytomegalovirus may be the agent that initiates this 
multifocal malignancy. Multiple factors must be in­
volved in this process. It is known that some immuno­
suppressed individuals develop Kaposi's sarcoma, which 
completely resolves when the immunosuppression is re­
versed; however, in individuals with classical Kaposi's 
sarcoma, the profound degree of helper T-cell depres­
sion that characterizes the acquired immune deficiency 
syndrome is not seen. 
WHERE DID THE AIDS EPIDEMIC COME FROM? 
In 1872, the Hungarian dermatologist Moritz (Kohn) Kaposi 
described multiple idiopathic hemorrhagic sarcoma [1], a rare 
multifocal sarcoma that generally begins as small violaceous 
papules and nodules on the lower extremities of elderly men. 
These lesions enlarge and coalesce to form plaques, nodules, 
and tumors, which untreated can reach giant configurations. 
The tumors are generally red or purple in hue in light-skinned 
individuals and purple to brownish in dark-skinned individuals. 
As the lesions become older, they darken in color, progressing 
from red to dark purple to brown. Lesions may be 10 cm or 
larger and may number from one to hundreds in a single patient. 
The lesions generally begin on the lower extremities, but they 
can also been seen on the upper extremities, and scattered 
lesions can occur on the trunk, head, neck, and genitalia. 
Nodules and tumors may cluster along veins, especially on the 
lower extremities. Early lesions are not palpable, but as the 
lesions age, they become rubbery and compressible. Generally, 
lesions are asymptomatic, but patients can experience burning, 
itching, or pain. Edema of the lower legs is common and is 
generally of the persistent or brawny type rather than pitting 
in nature. The edema may be so severe as to restrict walking. 
Lesions will occasionally outgrow their blood supply and show 
central infarction and regression. 
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Internal organs can be involved. The most common lesions 
are in the mouth and gastrointestinal tract. Lesions have been 
described on the tonsils and in the lungs, adrenal glands, spleen, 
liver, kidney, pericardium, and bone. Occasionally, the disease 
will be exclusively visceral without cutaneous lesions. Death 
generally occurs from generalized disease with cachexia, hem­
orrhage, or impairment of vital organ function by tumor prolif­
eration [2-5]. 
The disease did not receive widespread attention until the 
1960s, when it was recognized that large numbers of cases of 
Kaposi's sarcoma occur in equatorial Africa. This area is pri­
marily composed of open bush country and rolling hills. The 
altitude is between 1200 and 1500 m. The region includes 
Uganda, Kenya, Tanzania, and Zaire. Kaposi's sarcoma in this 
area is strikingly frequent, comprising between 3% and 10% of 
all malignant tumors as compared with only 0.02% of malig­
nancies reported in the United States. The African cases were 
extensively studied by Templeton and Huh [6]. In addition to 
the classical nodular presentation, three additional clinical 
presentations were recognized-an exophytic or florid form, an 
infiltrative form, and a lymphadenopathic form. The nodular 
type was the most common and may coexist with other aggres­
sive forms of Kaposi's sarcoma. The nodular type is generally 
indolent and shows a variable response to chemotherapy. Spon­
taneous remissions were seen. The exophytic or florid variety 
was usually rapid growing; ulceration, secondary infection, and 
hemorrhage were common. These tumors may extend deep into 
the dermis and involve underlying muscle or bone. Generally, 
the exophytic or florid form responds dramatically to chemo­
therapy. The infiltrative type usually occurs on an extremity 
and shows deep invasive penetration of tumor into muscle and 
bone. These lesions are genera lly of long duration and respond 
poorly to chemotherapy. The lymphadenopathic type occurs 
most commonly in children and is otten rapidly progressive. 
This form, of course, is easily confused with a lymphoma. 
Because of the rapid growth of these lesions, the prognosis was 
generally poor until aggressive chemotherapy was introduced. 
Recent reports have indicted a favorable response to chemo­
therapy with some long-term survivors [7J. 
The histologic pattern of each of these types of Kaposi's 
sarcoma is useful in predicting the natural history of the disease 
and the patient's response to therapy [8]. As seen in Table I, 
the nodular and lymphadenopathic forms of Kaposi's sarcoma 
show a histologic picture composed of both spindle cells and 
numerous vascular slits. The infiltrative form shows a mono­
cellular histologic pattern composed predominantly of spindle 
cells and frequent plasma cells. The exophytic or florid type 
shows both mixed cells and monocellular patterns with occa­
sional anaplastic presentation. 
In the 19708 it was also realized that Kaposi's sarcoma was 
seen as an opportunistic malignancy in individuals who were 
iatrogenicly immunosuppressed [9,10]. Two reports were pre­
sented as confirmation that the immunosuppression was piv­
otal to the appearance of the disease-one a case of temporal 
arteritis and the other a case of asthma-both were treated 
with prednisone and Kaposi's sarcoma developed after the 
patient was immunosuppressed [11]. In both instances, the 
corticosteroids were discontinued and the Kaposi's sarcoma 
totally regressed as the patient's immune system recovered. 
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TABLE I. Correlation between gross and microscopic tumor 
morphology in 37 Ugandan patients 
--------
Histologic pattern 
Tumor type 
Mixed cell Monocellular Anaplastic 
Nodular 9 1 0 
Florid 6 7 3 
Infiltrative 1 4 0 
Lymphadenopathic 6 0 0 
Source: From Taylor et al [8]. 
TABLE II. Acquired immune deficiency syndrome (AIDS): Weekly 
surveillance report of US. cases reported to CDC (November 15, 198:1) 
Primary diseaseQ 
KS without PCP 
PCP without KS 
Both KS and PCP 
- -- --
01 without KS or PCP 
Total 
- --
Cases 
722 
1407 
193 
4:31 
2753 
Percent 
of total 
26.2 
51.1 
7 .0 
15.7 
100.0 
-- - ----- ---
Deaths Percent dead 
1.51 20.9 
644 45.8 
113 fi8.6 
218 fiO.6 
1126 40.9 
" KS = Kaposi's sarcoma, PCP = Pneumocystis carinii pneumonia, 
01 = other opportunistic infections. 
Source: From AIllS Activity Center for Infectious Diseases [13]. 
TABLE III. Distribution of Kaposi's sarcoma and Pneumocystis carinii 
pneumonia by risk group 
Homosexuals 
IV Drug Users 
Haitians 
Hemophiliacs 
Unknown 
No. of cases 
727 
1fifi 
50 
7 
61 
1000 
No. of Kaposi's 
sarcoma cases (%) 
342 (47%) 
6 (4%) 
2 (4%) 
0-
16 (26%) 
No. of Pneumocystis 
pneumonia cases (%) 
385 (53%) 
149 (96%) 
48 (96%) 
7 (100%) 
45 (74%) 
Source: From H ,Jaffe. personal communication. 
In the summer of 1981, the Centers for Disease Control 
reported cases of Kaposi's sarcoma from New York and a 
variety of opportunistic infections from southern California 
[12]. Both these highly unusual outbreaks were combined as a 
single report because they shared the epidemiologic features 
occurring in young homosexual men who had been sexually 
promiscuous. Thus we were first notified of the appearance of 
what has come to be called the acquired immune deficiency 
syndrome (AIDS). 
In retrospect, it would appear that there were two or thr('e 
cases in 1978, 7 or 8 cases in 1979, and then an exponential 
rise in the number of cases since that time. Currently, there is 
a doubling of cases every 6 months . By November of 1983, over 
2753 cases had been reported in the United States . 
Table II shows that half the cases have presented with 
Pneumocystis carinii pneumonia without Kaposi's sarcoma, and 
only 25% of the cases have presented with Kaposi's sarcoma 
without Pneumocystis pneumonia. What Table II does not show 
is the striking difference in presentation of disease between the 
two high- risk groups. Male homosexuals present with Pneu­
mocystis pneumonia 53% of the time and Kaposi's sarcoma 
47% of the time (Table III). IV drug users have Pneumocystis 
pneumon ia 96% of the time and Kaposi 's sarcoma only 4% of 
the time. 
Table IV indicates an overall mortality rate of 40%. Unfor­
tunately, this figure is artifically low because of the rapid 
appearance of new cases. The overall mortality rate of Pnell­
mocystis carinii pneumonia approaches 100% by 18 months 
after the initial diagnosis. The prognosis for patients presenting 
with Kaposi's sarcoma is somewhat better, with a 20 to 30% 
survival rate at 2 years. 
Table IV shows that half the cases occur in men in the :3()-
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40 age group, with a peak age at about 36. This is intriguing 
when we recall that the peak age for other sexually transmitted 
diseases, such as syphilis, gonorrhea, and hepatitis B, is in the 
midtwenties, a full decade earlier. Does this suggest that some 
disease such as hepatitis B acquired in the third decade of life 
predisposes to this new disease in the fourth decade? Could 
there be other factors introduced in the third decade of life, 
such as exposure to semen, drugs, or allogenic T-lymphocytes, 
or the loss of some natural resistance, such as interferon, which 
predisposes the homosexual patient to the AIDS agent in the 
next decade of life? 
Table V shows the racial/ethnic distribution of American 
cases. The percentage of blacks suffering from AIDS is higher 
than the percentage of black people in this country. It is not 
clear whether this increase is due to a genetic susceptibility of 
blacks to Kaposi's sarcoma, as suggested by the endemic focus 
of the disease in equatorial Africa, or because of the high 
incidence of AIDS among intravenous drug abusers, many of 
wbom are black. San Francisco has the second highest inci­
dence of AIDS in the United States because of its large homo­
sexual population. Twenty-five percent of the population of 
San Francisco is Asian, and yet we know of only one Asian 
case occurring in our area. Clearly, epidemiologic studies of 
Asians is urgently needed to tell us if the Asian homosexual 
male engages in the same sexual practices and has the same 
rate of promiscuity as his Caucasian counterpart or if Asians 
are in some way genetically protected from this new disease. 
Table VI shows that most of the eases have been homosexual 
males and intravenous drug abusers. These percentages have 
remained constant since the beginning of the epidemic in 1980, 
indicating that the disease is not spreading to other segments 
TABLE IV. Acquired immune deficiency syndrome (AIDS): Weekly 
surveillance report of US. cases reported to CDC (November 15, 1983) 
Age Cases Percent of total 
Under 20 13 0.5 
20-29 610 22.1 
30-39 1280 46.5 
40-49 595 2l.6 
Over 49 247 9.0 
Unknown 8 0.3 
Total 2753 100.0 
Source: From AIDS Activity Center for Infectious Diseases [13]. 
TABLE V. Acquired immune deficiency syndrome (AIDS): Weekly 
surveillance report of US. cases reported to CDC (November 15, 1983) 
Race/ethnicity Cases Percent of total 
White, not Hispanic 1588 57.7 
Black, not Hispanic 713 25.9 
Hispanic 393 14.3 
Other 10 0.3 
Unknown 49 1 .8 
Total 2753 100.0 
Source: From AIDS Activity Center for Infectious Diseases [13]. 
TABLE VI. Acquired immune deficiency syndrome (AIDS): Weekly 
surveillance report of us. cases reported to CDC (November 15, 1983) 
- - ------
Patient 
characteristics 
Homosexual or bisexual 
Intravenous (IV) drug 
users 
Haitian 
Hemophiliac 
None apparent/unknown 
Total 
----- -- -
Males Females Total 
Cases Percent Cases Percent Cases Percent 
1964 76.5 0 0.0 1964 7l.3 
374 14.6 99 53.5 473 17.2 
113 4.4 18 9.7 131 4.8 
18 0.7 0 0.0 18 0.6 
99 3.8 68 36.8 167 6.1 
2568 100.0 1R5 100.0 2753 100.0 ----------
Source: From AIDS Activity Center for Infectious Diseases [13]. 
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TABLE VII. No risk fact()rs�I:JO cases (June 1981 throuRh September 
1983) 
Transfusion in previous 5 years 
Sexual partners of cases 
Background opportunistic infections 
Background Kaposi's sarcoma 
Typical AIDS wit h no known risk 
No. of cases (%) ---
22(17%) 
20 (15%) 
15 (12%) 
13 (10%) 
60 (46%) 
Source: From H ,Jaffee, personal communication. 
TABLE VIII. Acquired immune deficiency syndrome (AIDS). Weekly 
surveillance report of u.s. cases reported to CDC (November 15, 1983) 
Residence No. of cases Percent of total 
New York State 1251 45.4 
New York City 1060 38.5 
Other, New York 191 6.9 
California 599 21.8 
San Francisco 333 12.1 
Los Angeles 203 7.4 
Other, California 63 2.3 
Florida 204 7.4 
Miami 124 4.5 
Other, Florida 80 2.9 
New.Jersey 170 6.2 
Newark 77 2.8 
Other, New ,Jersey 93 3.4 
Texas 87 3.1 
Illinois 50 1.8 
Pennsylvania 49 1.8 
Massachusetts 38 1.4 
Georgia 33 1.2 
Connecticut 26 0.9 
Colorado 25 0.9 
Maryland 25 0.9 
Virgin ia 24 0.9 
Washington, D.C. 22 0.8 
Ohio 15 0.5 
Puerto Rico 13 0..') 
Louisiana 12 0.4 
Arizona 10 0.4 
South Carolina 10 0.4 
Other states (26) 90 3.3 
Total�United States 2753 100.0 
Source: From AIDS Activity Center for Infectious Diseases [13]. 
of society. Jaffee has analyzed the first 130 cases with no 
apparent risk factors from 1981 through September of 1983. As 
can be seen in Table VII, about 30% of the cases were exposed 
to either blood or blood products or were the sexual partners 
of individuals with AIDS. Twenty percent of the cases appeared 
to represent background infections or background cases of 
Kaposi's sarcoma . About 50% had typical AIDS with no known 
risk factors. It should be noted, however, that many of these 
cases were dead when this study was done and, consequently, 
detailed sexual and social histories were impossible to obtain. 
Table VIII shows the number of cases in the United States 
by state. Half the cases have been reported from New York and 
New ,Jersey, with 20% from California and 7% from Florida. 
An increasing number of foreign countries have begun to 
report cases of AIDS. As of November 15, 1983, 50 cases had 
been reported from Canada, with an epidemic pattern almost 
identical to that seen in the United States. Table IX shows the 
European cases reported as of October 20, 1983. Twenty-two 
percent of the 268 European cases were individuals born in 
Africa. Of the African cases, 37% were women. This is partic­
ularly significant. In the United States and Canada and among 
Europeans with AIDS, only about 5% of the cases have occurred 
in women. Reports from Haiti and Zaire and the African cases 
reported from Europe indicate a much higher incidence of the 
disease in women from these areas. 
The excellent and illustrative data compiled by Professor 
Koch and his colleagues of the Robert Koch Institute in Berlin 
(Fig 1) clearly show that the epidemic of AIDS in San Francisco 
and in West Germany parallels the epidemic in New York, with 
an identical incidence rate separated only by time. 
The situation in Haiti and Zaire is less clear. The epidemic 
was noted in Haiti in 19 79, and as of November 1983, 202 cases 
have been reported. Most of the patients are in their midthir­
ties, with 85% men and 15% women [15]. It is not yet clear if 
the mode of transmission is the same in Haiti as that noted in 
TABLE IX. Cases of AIDS reported to the European regional office of 
the World Health Organization (October 20, 19H3) 
Country 79 1979 1980 1981 1982 ]983 Total 
Austria 7 7 
Belgium 2 4 8 24 38 
Czechoslovakia 1 2 
Finland 2 2 
France 6 5 5 30 47 94 
West Germany 7 33 42 
Ireland 2 2 
Italy 1 2 3 
Netherlands 3 9 12 
Norway 2 2 
Spain 4 6 
Sweden 1 :� 4 
Switzerland 2 3 5 7 17 
United Kingdom 2 5 17 24 
Total 8 2 10 17 67 164 268" 
" East Germany, Greece, Hungary, Luxembourg, Poland, USSR, and 
Yugoslavia reported no cases. No information was received from other 
countries. 
Source: From European Regional Office of World Health Organi-
zation [14]. 
USAI AIDS CASES NYC TOTAL NUMBER SF D 
2 1000 
1000, 500 
FIG 1. Travel histories to the United States, Haiti, and Africa (last 
5 years, written reports). 
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the United States and Canada. Forty-nine cases were described 
in Kinshasa, Zaire, in the fall of 1983. Forty-one percent of 
these cases were women. Comparisons between American and 
European cases and Haitian and African cases must be made 
with great caution. The two areas are not comparable because 
of different standards of living, different cultural mores, and 
different availabilities of trained health care professionals. In 
Haiti and Zaire, intractable diarrhea and progressive tubercu­
losis appear to be the two most common manifestations of 
AIDS, followed by esophygeal candidiasis and toxoplasmosis. 
Pneumocystis pneumonia is seen less frequently and Kaposi's 
sarcoma is rare. This is clearly a different pattern of disease 
than that reported in the United States and Europe, but it may 
represent the same syndrome in a developing nation. 
WHAT IS THE CAUSE OF AIDS? 
Early attempts to explain this new epidemic centered on 
investigations of the lifestyles of patients with reported cases 
in the hope of finding some environmental factor (such as the 
recreational drug amyl nitrate), or repeated exposure to sex­
ually transmitted diseases, or treatment of one of these sexually 
transmitted diseases that might suppress the immune system 
of individuals and allow the opportunistic infection or the 
opportunistic malignancy to appear. Unfortunately, no envi­
ronmental factor was easily demonstrable. Indeed, as the epi­
demic grew, it became more and more apparent that the epi­
demiologic pattern was similar to the groups at risk for acquir­
ing hepatitis B. The groups at risk for hepatitis B are male 
homosexuals, prostitutes, intravenous drug abusers, prisoners, 
family members of individuals with hepatitis B infection, in­
fants of mothers with hepatitis B infection, residents and staff 
of institutions for the mentally retarded, patients and staff of 
hemodialysis units, hemophiliacs, nurses, physicians, medical 
students, and oral surgeons. AIDS has been diagnosed in most 
of these groups. In the fall of 1983, 76% of all of the AIDS 
patients gave a history of homosexual or bisexual behvior, 15% 
of the patients were intravenous drug users, 1 % of the patients 
were hemophiliacs, and 3-5% of the patients did not fall into 
any known risk group [16]. The disease had been seen in 
homosexual prisoners [17], and one case of an infant who 
received an exchange transfusion of blood that was donated by 
a healthy homosexual man who later developed AIDS has been 
reported. Dr. Arthur Ammann has reported four infants born 
of an intravenous drug abusing mother who show evidence of 
AIDS [18-20], and an increasing number of cases are being 
described in women whose only risk factors appear to be that 
their sexual partners are either intravenous drug abusers or 
bisexual men [21]. AIDS has occurred in health care providers, 
but all these individuals appear to be homosexual men. No case 
of AIDS in a health care provider has yet been directly linked 
to exposure to a patient suffering from the disease [19]. Unfor­
tunately, if the mode of transmission is by exposure to blood 
or blood products, we can expect to eventually see a case of 
AIDS in a health care worker who accidentally inoculates 
himself or herself by an inadvertent needle stick. 
The parallels between the individuals who develop the ac­
quired immune deficiency syndrome and those at risk Jor 
developing hepatitis B are so strong that most investigators 
currently favor the hypothesis that AIDS is caused by a blood­
borne sexually transmitted agent that has newly been intro­
duced into extremely high risk populations-namely, sexually 
promiscuous homosexual men and intravenous drug abusers. 
WHAT IS THE AIDS AGENT? 
Everything that we know about the AIDS epidemic is based 
on epidemiologic information. To date, no one has isolated the 
AIDS agent, and no laboratory test has been developed that 
clearly delineates those individuals who have been infected 
from those who have not. The most likely candidate is a yet 
unidentified retrovirus not previously introduced into the at 
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risk population, where it is currently spreading at an exponen­
tial rate. This agent may have existed in some animal other 
than humans for centuries, but previous inoculation of humans 
was unrecognized and did not lead to the introduction of the 
agent into a high-risk group. If this is true, then adaptation of 
the virus to its new host may still be occurring. The agent may 
become more or less virulent as adaptation progresses, but 
reports from physicians caring for patients with AIDS would 
suggest that changes have not yet been noted. The appearance 
of the opportunistic infections and opportunistic malignancies 
remains the same, and the complications and death rate from 
the disease appear the same today as when the epidemic was 
first noted in 1980. 
The mode of spread of the agent also remains unchanged. 
An analysis of the first 500 cases of AIDS that occurred in the 
4 years between 1978 and 1982 and the last 500 cases that 
occurred in the 4 weeks of September 1983 shows that the same 
percentage of cases are homosexual men, intravenous drug 
users, hemophiliacs, and Haitians in the first 500 cases and in 
the last 500 cases. This strongly suggests that the epidemic is 
not spreading to other groups in the population. 
A popular hypothesis has held that the AIDS agent is the 
one responsible for the endemic focus of Kaposi's sarcoma that 
has been known in Africa for years. A variety of arguments can 
be mounted against this theory. First, as seen in Table X, the 
clinical presentation and course of Kaposi's sarcoma in Africa 
have many features quite different from those seen in endemic 
Kaposi's sarcoma. Second, while case histories in certain rural 
parts of Africa are extremely difficult to obtain, the number of 
deaths from Pneumocystis pneumonia and other opportunistic 
infections seen in the AIDS epidemic are not occurring with 
the same frequency in Africa. Finally, had the disease been 
present in Africa for many years, earlier exposure to the homo­
sexual community or to an intravenous drug abuser should 
have occurred. 
Human T-cell leukemia virus (HTL V) has recently been 
linked to AIDS by investigators from Harvard, the National 
Cancer Institute, and the Institute Pasteur. Feline leukemia 
virus is known to be associated with prolongation of allograft 
rejection, thymic atrophy, depletion of paracortical lymphoid 
tissue, decreased response to T-cell mitogens, and depressed 
peripheral blood lymphocyte counts [22]. Indeed, cats infected 
with feline leukemia virus die more frequently from opportun­
istic infections than from leukemia. Essex and McLane, at 
Harvard, have shown antibodies against membrane-associated 
antigens of HTL V in 30% of 75 patients with AIDS [23]. 
Gelmann and Popovic were able to demonstrate viral DNA in 
the cells of 2 of 33 AIDS patients [24] . 
Finally, Luc Montagnier, of the Institute Pasteur, has iso­
lated a new strain of HTL V from a homosexual male who 
appears to suffer from the gay lymph node syndrome, which is 
considered by many to represent an individual who has been 
infected with the AIDS agent but the only manifestation of the 
disease is mild leukopenia, marked helper T-cell depression 
(0.8:1), and reactive hyperplasia of posterior cervical and axil­
lary lymph nodes. Human T-cell leukemia virus, which was 
initially described in 1981, was first isolat�d from an American 
patient with mycosis fungoides. Subsequently, the same virus 
was found in individuals with lymphoid malignancies in the 
United States, the Caribbean, and southern Japan. Another 
malignancy known to be caused by human T-cell leukemia 
TABLE X. 
Classical African AIDS 
Cutaneous location Lower legs -Extremities Generalized 
Mucosal involvement Rare Rare Common 
Node involvement Rare Uncommon Frequent 
Indolent course Common Common Unusual 
Response to treatment Excellent Excellent Poor 
July 1984 VIRAL ETIOLOGY OF AIDS AND KAPOSI'S SARCOMA 61s 
virus is hairy cell leukemia. This malignancy however, is caused 
by a second strain of HTL V. The agent isolated at the Institute 
Pasteur in the man with the gay lymph node syndrome would 
appear to be a third strain of HTLV virus [25]. 
A DNA arbovirus transmitted by ticks to wild swine in Africa 
was recently suggested as a possible etiologic agent for AIDS 
by Dr. Jame Teas [26]. Dr. Teas points out that the epidemic 
of African swine fever virus appeared in Haiti at about the 
same time that the AIDS epidemic occurred. She postulates 
that this highly variable agent infected individuals who con­
sumed uncooked pork. Early studies looking for antibodies to 
African swine fever virus have failed to demonstrate antibodies 
in AIDS patients. 
Dr. Larry Drew and coworkers [27] demonstrated that 94% 
of homosexual males and only 54 % of heterosexual males 
showed past infection with cytomegalovirus. For this reason, 
an early theory was that the immunosuppression of AIDS was 
caused by a new and virulent mutant of cytomegalovirus. It is 
known that cytomegaloviral infection can cause cervical lymph­
adenopathy similar to that seen in patients with the gay lymph 
node syndrome and that marked helper T-cell depression can 
occur for up to 8 months following cytomegaloviral mononu­
cleosis. While most patients with AIDS show active cytome­
galoviral infection, endonuclease restriction enzyme analysis 
shows a variable pattern of cytomegalovirus (CMV) infection 
in gay men and does not support the hypothesis that there is a 
single new mutant responsible for the current epidemic. Drew's 
original work on the prevalence of cytomegalovirus infection in 
homosexual men was done before the AIDS epidemic was seen 
in San Francisco, and it is known that cytomegalovirus infec­
tions are common in homosexual men in numerous cities where 
cases of AIDS have not yet been seen. For these reasons, CMV 
is not considered a likely candidate as the AIDS agent. 
Epstein-Barr virus (EBV) antibodies are elevated in most 
AIDS patients, and the virus has been recovered in some cases. 
The antibody patterns, however, suggest reactivation of a latent 
infection and not a newly acquired immunosuppressive disease. 
Dr. Pieter J. de Jong and his colleagues, at the Albert Einstein 
College of Medicine and the Montefiore Medical Center, have 
recovered 13 adenovirus isolates from 10 patients with AIDS. 
Endonuclease restriction enzyme analyses of these isolates 
show 12 to be adenovirus-35 and 1 to be adenovirus-3 4 .  Aden­
ovirus is known to remain in tonsillar tissue for long periods 
after infection. However, reactivation in an immunosuppressed 
individual should show a variety of the 39 known serotypes of 
adenovirus and not be limited to just serotype 35. Our group in 
San Francisco is recovering adenovirus in the semen of about 
12% of all immunosuppressed homosexual men seen in our 
clinics. These isolates are currently being serotyped. 
Parvovirus is an attractive agent as the cause of AIDS. This 
small DNA virus is known to cause Aleutian mink disease, 
which is characterized by clinical features suggestive of AIDS, 
including generalized lymphadenopathy, progressive immune 
complex disease, the production of autoantibodies, and pro­
gressive polyclonal hypergammaglobulinemia. Genetic predis­
position is critical to Aleutian mink disease. This disease is 
universally fatal to Aleutian mink, but other species of mink 
are not susceptible. Parvovirus appeared de novo in the canine 
population of this country in 1972 and has caused widespread 
mortality and morbidity among household pets. The sudden 
appearance of this agent in dogs underscores the fact that a 
new viral agent can suddenly appear and spread in a susceptible 
population, much as we have seen in the AIDS epidemic. 
No single agent has yet been incriminated as the cause of 
acquired immune deficiency syndrome. Individuals suffe:i�g 
from AIDS are at risk of acquiring a variety of opportumstlc 
infections including viral infections. Further, because of the 
profound immunosuppression, reactivation of a previous viral 
infection is possible. Confirmation that some virus is the cause 
of this new disease will require demonstration of antibodies to 
the virus in a large percentage of patients with AIDS and the 
gay lymph node syndrome and a demonstration of tl�e same 
viral agent in AIDS patients from different geographiC loca­
tions. 
DOES CYTOMEGALOVIRUS CAUSE KAPOSI'S 
SARCOMA? 
While it does not appear that cytomegalovirus is the agent 
responsible for the severe immunosuppression characteristic of 
AIDS, it may well be that this virus in a severely immunocom­
promised individual may be the etiologic factor responsible for 
the appearance of the opportunistic malignancy Kaposi's sar­
coma. In the 1970 s, Giraldo was able to demonstrate cytome­
galovirus from some African cases of Kaposi's sarcoma [28]. 
However, the African Kaposi's sarcoma patients failed to dem­
onstrate a serologic association between Kaposi's sarcoma and 
cytomegalovirus. A subsequent study by Giraldo showed sero­
logic association between cytomegalovirus antibodies and the 
presence of Kaposi's sarcoma in American patients [29]. In this 
study there was an association between CMV antibodies and 
Kaposi's sarcoma as opposed to the presence of CMV antibodies 
in melanoma patients. The study was not statistically signifi­
cant, however, because of the high background incidence of 
cytomegalovirus infection in the control population. 
In 1972, Giraldo demonstrated typical herpes-like virus p�r­
ticles in 5 of 8 tissue culture lines derived from cases of KapOSI's 
sarcoma [28]. In work that we have done at the University of 
California, San Francisco, we have not been able to demon­
strate cytomegalovirus or any other virus in material taken 
from cutaneous lesions of epidemic Kaposi's sarcoma or from 
4 cases of traditional Kaposi's sarcoma [30]. Ewing and asso­
ciates [31] have shown vesicular rosette structures in the lymph 
nodes of 17 of 18 patients with gay lymph node syndrome and 
3 of 6 patients who died of AIDS. Whether these unusual 
structures represent some infectious agent or will prove to be 
some type of artefact is still controversial. 
Drew [32] showed CMV IgG in 9 of 9 homosexual men with 
epidemic Kaposi's sarcoma and CMV IgM in 7 of9 of the same 
patients. Cytomegalovirus was recovered from the semen or 
blood of 7 of 10 of these patients. Kaposi's sarcoma tumor 
tissue was cultured for cytomegalovirus. Eight of 8 cultures 
were negative; however, 6 of 9 tumors showed CMV DNA 
antigens, and 2 of 3 tumors showed CMV RNA by in situ 
hybridization. These findings suggest that not only is CMV 
DNA present in the tumor of Kaposi's sarcoma, but it is also 
demonstrating activity by encoding for CMV messenger RNA. 
As with the association that has been demonstrated between 
herpes type II and cervical cancer, these findings do not prove 
that CMV is the cause of Kaposi's sarcoma, but they clearly 
show a strong relationship between this virus and the malig­
nancy. 
The AIDS epidemic is just beginning and has already caused 
extreme suffering and the needless deaths of large numbers of 
young adults. The cost to society has been great and may be 
staggering before this disease can be contained. Hopefully, out 
of this calamity we will gain greater insights into how viral 
agents suppress normal immune function and clarify the role 
of cytomegalovirus in the etiology of Kaposi's sarcoma. 
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